BioServe, a provider of genomics services, has expanded its relationship with Fox Chase Cancer Center, a foundation member of the BioServe Network.
Subscribe to our email newsletter
BioServe will help Fox Chase provide next generation sequencing capabilities as it has developed a new internal laboratory utilizing next-generation sequencing and analysis platforms and novel biological information technology systems for advanced analysis of genomic data.
BioServe’s BioRepository contains high-quality, high-yield DNA ready for next generation sequencing analysis, besides having high quality samples ready for cancer genome analysis.
BioServe president Rama Modali said the company is happy to offer next generation sequencing through Fox Chase.
"BioServe is uniquely positioned to be a single partner that can provide high quality human tissue samples and generate validated data from those samples to accelerate discovery," Modali added.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.